Li L - Search Results

1

Expression of CCL18 gene in ovarian cancer and its impact on the biologic function of ovarian cancer cells.

Yang YZ, Zhang W, Zhao BB, Li L. Yang YZ, et al. Among authors: li l. Int J Clin Exp Pathol. 2019 Jul 1;12(7):2572-2584. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31934085 Free PMC article.

2

Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer.

Zou J, Yin F, Wang Q, Zhang W, Li L. Zou J, et al. Among authors: li l. Int J Clin Exp Pathol. 2015 Jun 1;8(6):6847-58. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261572 Free PMC article.

3

CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway.

Wang Q, Tang Y, Yu H, Yin Q, Li M, Shi L, Zhang W, Li D, Li L. Wang Q, et al. Among authors: li d, li m, li l. Mol Carcinog. 2016 Nov;55(11):1688-1699. doi: 10.1002/mc.22419. Epub 2015 Oct 12. Mol Carcinog. 2016. PMID: 26457987 Free PMC article.

4

[Cisplatin resistant effects of dihydrofolate reductase gene expression up-regulation in epithelial ovarian cancer].

Li Z, Wang Q, Zhang W, Yang Z, Li L. Li Z, et al. Among authors: li l. Zhonghua Fu Chan Ke Za Zhi. 2015 Nov;50(11):854-60. Zhonghua Fu Chan Ke Za Zhi. 2015. PMID: 26887775 Chinese.

5

Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer.

Wu W, Wang Q, Yin F, Yang Z, Zhang W, Gabra H, Li L. Wu W, et al. Among authors: li l. Int J Oncol. 2016 Oct;49(4):1651-65. doi: 10.3892/ijo.2016.3652. Epub 2016 Aug 10. Int J Oncol. 2016. PMID: 27511453 Free article.

6

The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer.

Yang ZJ, Zhao BB, Li L. Yang ZJ, et al. Among authors: li l. J Ovarian Res. 2016 Sep 15;9(1):57. doi: 10.1186/s13048-016-0266-3. J Ovarian Res. 2016. Retraction in: J Ovarian Res. 2022 Jul 1;15(1):76. doi: 10.1186/s13048-022-01008-x PMID: 27629537 Free PMC article. Retracted.

7

STROBE-compliant integrin through focal adhesion involve in cancer stem cell and multidrug resistance of ovarian cancer.

Wei L, Yin F, Zhang W, Li L. Wei L, et al. Among authors: li l. Medicine (Baltimore). 2017 Mar;96(12):e6345. doi: 10.1097/MD.0000000000006345. Medicine (Baltimore). 2017. PMID: 28328815 Free PMC article.

8

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells.

Huang MJ, Zhang W, Wang Q, Yang ZJ, Liao SB, Li L. Huang MJ, et al. Among authors: li l. J Ovarian Res. 2018 Feb 13;11(1):15. doi: 10.1186/s13048-018-0387-y. J Ovarian Res. 2018. PMID: 29433550 Free PMC article.

9

Relationship between inter-α-trypsin inhibitor heavy chain 4 and ovarian cancer.

Huang M, Zhang W, Zhao B, Li L. Huang M, et al. Among authors: li l. Chin J Cancer Res. 2019 Dec;31(6):955-964. doi: 10.21147/j.issn.1000-9604.2019.06.11. Chin J Cancer Res. 2019. PMID: 31949397 Free PMC article.

10

LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer.

Feng LY, Huang YZ, Zhang W, Li L. Feng LY, et al. Among authors: li l. J Ovarian Res. 2021 May 15;14(1):67. doi: 10.1186/s13048-021-00807-y. J Ovarian Res. 2021. PMID: 33992120 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,094 results

Search Page

Filters